Literature DB >> 3286329

Maturation of insulin response to glucose during human fetal and neonatal development. Studies with perifusion of pancreatic isletlike cell clusters.

T Otonkoski1, S Andersson, M Knip, O Simell.   

Abstract

The insulin release in response to glucose was studied in perifused isletlike cell clusters (ICCs) obtained from human fetal or neonatal pancreases at various stages of development: 12-15 gestational wk (n = 7), 17-20 wk (n = 13), 22.5 wk (n = 2, 1 diabetic pregnancy), and 26-44 wk (n = 6, postnatal samples). The ICCs were stimulated with 20 mM glucose and subsequently with 10 mM theophylline plus 20 mM glucose as a viability test. Insulin release increased to a detectable level (greater than 0.1 pg.ICC-1.min-1) during glucose stimulation in four of seven of the youngest fetuses. At 17-20 wk the basal rate of insulin release had increased by at least 15-fold above the detection limit (1.5 pg.ICC-1.min-1), and glucose promoted a sustained monophasic response that was on the average 1.6-fold higher than the basal level. The response was significant (P less than .05) in 9 of 13 experiments. With postnatal ICC (gestational age 26-44 wk), an early-phase peak response was observed in 5 of 6 experiments. The mean rates of insulin release after 5-12 min of glucose stimulation were 4.8 pg.ICC-1.min-1 in newborn infants and 2.1 pg.ICC-1.min-1 in 17- to 20-wk fetuses. The corresponding mean relative insulin responses (stimulated to basal) were 3.3-fold (range 1.1-7.5) and 1.6-fold (1.0-3.4), respectively (P less than .05, Mann-Whitney U test). The results suggest that the human fetal pancreas is already responsive to glucose during the first half of gestation, but the biphasic insulin release does not start to mature until the postnatal phase.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3286329     DOI: 10.2337/diab.37.3.286

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  24 in total

Review 1.  Fetal growth signals.

Authors:  R D Milner; D J Hill
Journal:  Arch Dis Child       Date:  1989-01       Impact factor: 3.791

2.  Islet amyloid polypeptide in proliferating pancreatic B cells during development, hyperplasia, and neoplasia in humans and mice.

Authors:  G Rindi; G Terenghi; G Westermark; P Westermark; G Moscoso; J M Polak
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

Review 3.  The fetus of the diabetic mother: growth and malformations.

Authors:  I Swenne
Journal:  Arch Dis Child       Date:  1988-10       Impact factor: 3.791

Review 4.  Early-life programming of susceptibility to dysregulation of glucose metabolism and the development of Type 2 diabetes mellitus.

Authors:  M J Holness; M L Langdown; M C Sugden
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

5.  Regulation of insulin release in persistent hyperinsulinaemic hypoglycaemia of infancy studied in long-term culture of pancreatic tissue.

Authors:  N Kaiser; A P Corcos; A Tur-Sinai; Y Ariav; B Glaser; H Landau; E Cerasi
Journal:  Diabetologia       Date:  1990-08       Impact factor: 10.122

6.  In vivo proliferation of differentiated pancreatic islet beta cells in transgenic mice expressing mutated cyclin-dependent kinase 4.

Authors:  S Hino; T Yamaoka; Y Yamashita; T Yamada; J Hata; M Itakura
Journal:  Diabetologia       Date:  2004-10-06       Impact factor: 10.122

7.  Nicotinamide is a potent inducer of endocrine differentiation in cultured human fetal pancreatic cells.

Authors:  T Otonkoski; G M Beattie; M I Mally; C Ricordi; A Hayek
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

8.  Age-Dependent Pancreatic Gene Regulation Reveals Mechanisms Governing Human β Cell Function.

Authors:  H Efsun Arda; Lingyu Li; Jennifer Tsai; Eduardo A Torre; Yenny Rosli; Heshan Peiris; Robert C Spitale; Chunhua Dai; Xueying Gu; Kun Qu; Pei Wang; Jing Wang; Markus Grompe; Raphael Scharfmann; Michael S Snyder; Rita Bottino; Alvin C Powers; Howard Y Chang; Seung K Kim
Journal:  Cell Metab       Date:  2016-04-28       Impact factor: 27.287

Review 9.  Review: Placental programming of postnatal diabetes and impaired insulin action after IUGR.

Authors:  K L Gatford; R A Simmons; M J De Blasio; J S Robinson; J A Owens
Journal:  Placenta       Date:  2010-01-22       Impact factor: 3.481

10.  Streptozotocin is not toxic to the human fetal B cell.

Authors:  B E Tuch; J R Turtle; C J Simeonovic
Journal:  Diabetologia       Date:  1989-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.